| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 13 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 10 | 0.0000 |
| 5 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Microtubule Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Aldosterone Antagonist [EPC] | 3 | 0.0000 |
| 8 | Corticosteroid [EPC] | 12 | 0.0000 |
| 9 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 10 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 11 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 12 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 13 | Vitamin C [EPC] | 1 | 0.0000 |
| 14 | Interleukin-4 Receptor alpha Antagonist [EPC] | 1 | 0.0000 |
| 15 | Kinase Inhibitor [EPC] | 1 | 0.0000 |